Cambridge Trust’s Inogen INGN Stock Holding History

Cambridge Trust’s Portfolio INGN Stock Details INGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-200	Closed	-$5K	–	833
2022 Q3	$5K	Hold	200	–	–	﹤0.01%	712
2022 Q2	$5K	Hold	200	–	–	﹤0.01%	740
2022 Q1	$6K	Hold	200	–	–	﹤0.01%	794
2021 Q4	$7K	Buy	+200	New	+$7.27K	﹤0.01%	864

Other funds holding INGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Cambridge Trust's INGN Position: Q4 2022 in Review

Cambridge Trust sold out of Inogen (INGN) in Q4 2022, closing a stake of 200 shares — an estimated $5K sold.

Cambridge Trust first reported a position in INGN in Q4 2021 and held it in 4 quarters. The position peaked at $7K in Q4 2021. 134 funds tracked by Wall St. Rank hold INGN as of Q4 2022.

Cambridge Trust reported no remaining Inogen position as of Q4 2022 after selling out during the quarter.
Cambridge Trust sold 200 Inogen shares in Q4 2022, an estimated $5K.
Cambridge Trust first reported a position in Inogen in Q4 2021 and held it in 4 quarters.
Cambridge Trust's Inogen position peaked at $7K in Q4 2021.
134 funds tracked by Wall St. Rank held Inogen as of Q4 2022.

Based on Cambridge Trust's 13F filing for Q4 2022, filed 10 Jan 2023.